Skip to content
TrialScanner

NCT04155710

Study of Autologous Peripheral Blood Lymphocytes in the Treatment of Patients With CLL or SLL

Phase 1CompletedIOVALead

Registry record

Lead sponsor
Iovance Biotherapeutics, Inc.
Conditions
Chronic Lymphocytic Leukemia; Small Lymphocytic Lymphoma
Primary completion
Nov 11, 2024Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT04155710 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT04155710: Study of Autologous Periphera... | TrialScanner